Introduction to the preface
The direction of modernization of Chinese medicine has been denied...
"The prevailing view is that reform is not appropriate at the moment, but the focus should now be on inheritance rather than development." At the National Pharmaceutical Industry Conference in 1958, the discussion on Traditional Chinese medicine extractants was heated.
In the following decades, in Japan, even a mature market of formula granules with an output value of 40 billion yuan was formed. China, on the other hand, can only serve as a provider of Chinese herbal medicines, located downstream in the industry.
Today, after more than half a century of difficult development in China, Chinese herbal formula granules have finally gained recognition in the controversy of continuous struggle, repeated scrutiny and questioning.
<h1 class="pgc-h-arrow-right" data-track="12" >01 The modernization direction of Chinese medicine has been denied</h1>
After 28 years of "pilot", the chinese medicine formula granules have finally "turned positive".
The Chinese medicine formula granules developed by the "reformists" in the TCM group nearly a century ago have finally been affirmed as the results of the efforts of "TCM modernization" after experiencing twists and turns.
Regarding the modernization of Chinese medicine, we have always misunderstood it, and people are always accustomed to equating the modernization of Chinese medicine with the westernization of traditional Chinese medicine.
In fact, the meaning of modernization is "to make it reach the advanced level of science and technology", and the modernization of Chinese medicine is not to use Western medicine to transform Chinese medicine, but to re-develop Chinese medicine from the most advanced understanding of mankind.
As one of the representative works of chinese medicine modernization, "Chinese medicine formula granules" has been full of controversy and ups and downs for many years.
■ From the 1920s to the 1950s, the chinese medicine community tried to mix the decoction liquid of single-flavor herbs, but it has not been successfully promoted.
■ Until the 1950s, as the director of Guangzhou Xingqun Chinese Medicine Distillery, Qiu Chenbo led Xingqun to launch more than 200 Chinese medicine refining products, which were not only popular in hospitals and clinics across the country, but also sold to Southeast Asia.
At the 1958 National Pharmaceutical Industry Conference, the discussion on Chinese medicine extractants was very enthusiastic, "The mainstream view is that it is not appropriate to carry out reform at present, on the grounds that the party's Chinese medicine policy is inherited and carried forward." But the focus now should be on inheritance, not development.".
This means that the direction of modernization of Chinese medicine has been denied.
Because of the limitation of vision, the industry did not realize at that time that for Traditional Chinese medicine, it is equally important to carry forward and inherit, and to use the most advanced modern technology to rediscover and prove the wisdom of the ancients, which is also inherited.
<h1 class="pgc-h-arrow-right" data-track="99" > 02 can only be used as a supplier of Chinese herbal medicines and is located downstream in the industry</h1>
Thirty years later...
■ In the 1980s, this compound granule developed by Japan has become the main product of Kampo Pharmaceutical Factory. This dosage form was later imitated by South Korea and Taiwan and other places, and became a common "concentrated Chinese medicine" granule, named "Kampo granules" and "scientific Chinese medicine", and the process has been quite mature.
In Japan, there is even a mature market with an output value of 40 billion yuan.
The domestic industry finally found that in the Chinese mainland, "many Chinese medicinal forms improved the production process design and operation methods of drugs, basically staying at the level of the early fifties.".
China can only serve as a provider of Chinese herbal medicines, located downstream in the industry.
The Chinese medicine community is once again aware of the need for dosage form improvement, and under the guidance of the policy, a new generation of Chinese medicine practitioners have once again begun to develop new Chinese medicine dosage forms.
■ In 1984, Zhang Zhiwei put forward a concept of the reform of Traditional Chinese Medicine Decoction: first boil the Chinese medicine tablets with water, and then concentrate and dry them at low temperatures to make a specified amount of dry granules. In the formulation, according to the requirements of the prescription, take each single flavor granule mixed and matched.
■ In 1987, the Ministry of Health and the State Administration of Traditional Chinese Medicine issued the "Opinions on Strengthening the Development of Chinese Medicinal Dosage Forms" and pointed out that "it is necessary to actively use modern science and technology and means to strengthen the development and development of new dosage forms", such as making commonly used Chinese medicine tablets into powders and granules.
■ In 1993, Chinese medicine formula granules were listed as the "Spark Plan" of the State Science and Technology Commission, and later included in the "Tenth Five-Year" Development Plan of Chinese Medicine and the "Action Plan for the Modernization of Science and Technology Industry of Chinese Medicine" and other policies.
This time, Chinese medicine granules officially took center stage.
<h1 class="pgc-h-arrow-right" data-track="100" > 03 Chinese medicine formula granules developed and entered the fast lane</h1>
After the 1990s, the development of Chinese medicine formula granules has been mentioned in a very important position.
■ In 2001, the national "Ninth Five-Year Plan" research project put forward for the first time a national strategy for the promotion of the modernization industry of traditional Chinese medicine.
The project is called "Research on the Promotion Strategy of the Modernization Industry of Chinese Medicine", and the research results clearly point out that the development direction of the Chinese medicine industry is "industrialization, scientific, modernization and internationalization".
Among them, the effective, portable, portable, convenient and convenient Chinese medicinal dosage forms are considered to be "a strong guarantee for enhancing market competitiveness and promoting the modernization of traditional Chinese medicine". The study also pointed out that modern dosage forms could be developed to open up international markets, compared with botanical medicines.
■ In the same year, China began to formally include Chinese medicine formula granules into the management of Traditional Chinese medicine tablets, and the former State Food and Drug Administration designated Tianjiang, Fangfang, Purapharm, New Green, Sanjiu, kangrentang 6 pharmaceutical companies to pilot production.
The development of chinese medicine formula granules has since entered the fast lane.
The wheels of history are rolling forward, and the time is coming to 2021.
■ On February 10 this year, the State Food and Drug Administration, the State Administration of Traditional Chinese Medicine, the National Health Commission and the National Medical Insurance Bureau jointly issued an announcement announcing that the pilot work of Chinese medicine formula granules that has been continued since 1993 will be terminated on November 1 this year.
In the future, all Chinese medicine enterprises can produce Chinese medicine formula granules, implement the filing system, and no longer need to apply for approval.
After more than half a century of difficult development, Chinese medicine formula granules have finally gained real recognition in the controversy of constant struggle, repeated scrutiny and questioning.
Chinese medicine has a long history of thousands of years in China, is a summary of the practical experience of working people in fighting diseases for a long time, and is the unremitting efforts of successive generations of doctors, which is gradually formed and developed in the process of continuous inheritance, innovation, re-inheritance and re-innovation.
We have reason to believe that the modernization and science and technology brought by chinese medicine formula granules can guide the overall progress of the Chinese medicine industry, better inherit the profound Chinese medicine, and carry forward it!
-END-